Again, these findings highlight the major discrepancies that can exist between different preclinical models (bacterial load at the initiation of the treatment, penetration of the antibiotic at the site of infection, use of mucin or not, route of bacterial inoculation, type of lung damage, etc.). Here, MUC5AC is linked to infection.